Restructuring






Sweet Baby J, it can't come soon enough....too many PCP CMH reps in small territories.....what do the insiders say?
The “insiders” say you’re an idiot if you believe there will be any “restructuring” anytime soon. Lilly will be launching Ordorglipron by 1st quarter of 2026 -if not sooner, and “Triple G” in 2027, and unfortunately for all you “Doomsday prophets”, Lilly will need sales reps for the launches, so -if anything- there will be a sales force expansion.
 






Neuro also going to be changing. They have told us it will definitely happen, but no indication yet of when. The Spec team has lost so many seasoned reps because they are disenchanted about calling on PCs without even having a product sell. All the Spec reps do is talk about blood biomarkers to help with Neuro referrals. Got to admit, if they offer any sort of package I'm out....too many other companies out there with good products, salaries and bonuses to stay here.
 

















Write your reply...